• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性泪腺肿瘤的联合治疗方法

Combined therapeutic approach to malignant lacrimal gland tumors.

作者信息

Byers R M, Berkeley R G, Luna M, Jesse R H

出版信息

Am J Ophthalmol. 1975 Jan;79(1):53-5. doi: 10.1016/0002-9394(75)90455-9.

DOI:10.1016/0002-9394(75)90455-9
PMID:162900
Abstract

The medical records of 13 patients with primary malignant lesions of the lacrimal gland revealed adenoid cystic carcinoma as the most common malignant tumor. The histologic cell type, neural invasion, and bony destruction were correlated with localized control and ultimate survival. Surgical removal of the lacrimal gland was adequate treatment for low-grade mucoepidermoid carcinoma confined to the gland itself. Combining a radical surgical removal of the area in planned sequence with high voltage radiation therapy offered the only reasonable hope for localized control in the more aggressive cell types or in tumors with neural invasion or bony involvement. A 40%-localized control and survival rate was achieved in the adenoid cystic carcinoma group of patients. Radiation therapy administered for cancer that obviously recurs after surgical resection was generally unsuccessful.

摘要

13例泪腺原发性恶性病变患者的病历显示,腺样囊性癌是最常见的恶性肿瘤。组织学细胞类型、神经侵犯和骨质破坏与局部控制及最终生存率相关。对于局限于泪腺本身的低级别黏液表皮样癌,手术切除泪腺是充分的治疗方法。对于更具侵袭性的细胞类型或伴有神经侵犯或骨质受累的肿瘤,按计划顺序进行根治性手术切除联合高电压放射治疗是实现局部控制的唯一合理希望。腺样囊性癌患者组的局部控制率和生存率为40%。对手术切除后明显复发的癌症进行放射治疗通常不成功。

相似文献

1
Combined therapeutic approach to malignant lacrimal gland tumors.恶性泪腺肿瘤的联合治疗方法
Am J Ophthalmol. 1975 Jan;79(1):53-5. doi: 10.1016/0002-9394(75)90455-9.
2
Multimodal therapy in the management of lacrimal gland adenoid cystic carcinoma.泪腺腺样囊性癌治疗中的多模态疗法
BMC Ophthalmol. 2019 Jun 8;19(1):125. doi: 10.1186/s12886-019-1110-5.
3
Outcomes in patients with adenoid cystic carcinoma of the lacrimal gland.泪腺腺样囊性癌患者的治疗结果。
Ophthalmic Plast Reconstr Surg. 2004 Jan;20(1):22-6. doi: 10.1097/01.IOP.0000105518.72611.4F.
4
Adenoid cystic carcinoma of salivary and lacrimal gland origin: localization, classification, clinical pathological correlation, treatment results and long-term follow-up control in 84 patients.涎腺和泪腺来源的腺样囊性癌:84例患者的定位、分类、临床病理相关性、治疗结果及长期随访
Anticancer Res. 2003 Mar-Apr;23(2A):931-40.
5
Long-Term Outcomes of Eye-Sparing Surgery for Adenoid Cystic Carcinoma of Lacrimal Gland.泪腺腺样囊性癌保留眼球手术的长期预后
Ophthalmic Plast Reconstr Surg. 2018 Jan/Feb;34(1):74-78. doi: 10.1097/IOP.0000000000000877.
6
Lacrimal Gland Adenocarcinoma Clinicopathologic Features and Outcomes Compared With Those of Lacrimal Gland Adenoid Cystic Carcinoma.泪腺腺癌的临床病理特征和结局与泪腺腺样囊性癌的比较。
Ophthalmic Plast Reconstr Surg. 2024;40(4):419-425. doi: 10.1097/IOP.0000000000002606. Epub 2024 Jul 3.
7
Epidemiology and treatment of lacrimal gland tumors: a population-based cohort analysis.泪腺肿瘤的流行病学和治疗:基于人群的队列分析。
JAMA Otolaryngol Head Neck Surg. 2014 Dec;140(12):1110-6. doi: 10.1001/jamaoto.2014.2846.
8
Adenoid Cystic Carcinoma from the salivary and lacrimal glands and the breast: Different clinical outcomes to the same tumor.涎腺和泪腺及乳腺腺样囊性癌:同一肿瘤不同的临床结局。
Crit Rev Oncol Hematol. 2022 Nov;179:103792. doi: 10.1016/j.critrevonc.2022.103792. Epub 2022 Aug 13.
9
Bone invasion by adenoid cystic carcinoma of the lacrimal gland: preoperative imaging assessment and surgical considerations.泪腺腺样囊性癌侵犯骨:术前影像学评估与手术考虑。
Ophthalmic Plast Reconstr Surg. 2010 Nov-Dec;26(6):403-8. doi: 10.1097/IOP.0b013e3181df6ab9.
10
Eye-sparing multidisciplinary approach for the management of lacrimal gland carcinoma.泪腺腺样囊性癌的保眼多学科治疗方法
Head Neck. 2016 Aug;38(8):1258-62. doi: 10.1002/hed.24433. Epub 2016 Mar 29.

引用本文的文献

1
Adenoid cystic carcinoma of the lacrimal gland - A major review.泪腺腺样囊性癌——一项主要综述。
Indian J Ophthalmol. 2025 Oct 1;73(10):1399-1411. doi: 10.4103/IJO.IJO_2560_24. Epub 2025 Sep 25.
2
Adenoid Cystic Cancer of the Lacrimal Gland: Management Aspects and Treatment Outcomes.泪腺腺样囊性癌:管理要点与治疗结果
Indian J Otolaryngol Head Neck Surg. 2024 Apr;76(2):2158-2161. doi: 10.1007/s12070-023-04426-5. Epub 2023 Dec 21.
3
Neoadjuvant Intra-Arterial Cytoreductive Chemotherapy for Lacrimal Gland Adenoid Cystic Carcinoma: A Long-Term Follow-up Study of a Trimodal Strategy.
新辅助动脉内细胞减灭化疗治疗泪腺腺样囊性癌:三联治疗策略的长期随访研究。
Am J Ophthalmol. 2022 Aug;240:239-251. doi: 10.1016/j.ajo.2022.03.027. Epub 2022 Apr 2.
4
Evolution of Care of Orbital Tumors with Radiation Therapy.眼眶肿瘤放射治疗的护理进展
J Neurol Surg B Skull Base. 2020 Aug;81(4):480-496. doi: 10.1055/s-0040-1713894. Epub 2020 Aug 24.
5
Multimodal therapy in the management of lacrimal gland adenoid cystic carcinoma.泪腺腺样囊性癌治疗中的多模态疗法
BMC Ophthalmol. 2019 Jun 8;19(1):125. doi: 10.1186/s12886-019-1110-5.
6
Three-Dimensional Multidetector CT for Anatomic Evaluation of Orbital Tumors.用于眼眶肿瘤解剖学评估的三维多探测器CT
J Ophthalmol. 2013;2013:674230. doi: 10.1155/2013/674230. Epub 2013 Oct 31.
7
Long-term outcomes of neoadjuvant intra-arterial cytoreductive chemotherapy for lacrimal gland adenoid cystic carcinoma.新辅助动脉内细胞减灭化疗治疗泪腺腺样囊性癌的长期疗效。
Ophthalmology. 2013 Jul;120(7):1313-23. doi: 10.1016/j.ophtha.2013.01.027. Epub 2013 Apr 9.
8
Skull base invasion of adenoid cystic carcinoma of the lacrimal gland : a case report.泪腺腺样囊性癌侵犯颅底:一例报告。
J Korean Neurosurg Soc. 2008 Oct;44(4):273-6. doi: 10.3340/jkns.2008.44.4.273. Epub 2008 Oct 30.
9
Clinical and microdissection genotyping analyses of the effect of intra-arterial cytoreductive chemotherapy in the treatment of lacrimal gland adenoid cystic carcinoma.动脉内减瘤化疗治疗泪腺腺样囊性癌效果的临床及显微切割基因分型分析
Trans Am Ophthalmol Soc. 2005;103:337-67.
10
Past, present, and future surgical management of malignant epithelial neoplasms of the lacrimal gland.泪腺恶性上皮性肿瘤的过去、现在及未来手术治疗
Br J Ophthalmol. 1986 Oct;70(10):727-31. doi: 10.1136/bjo.70.10.727.